Cargando…

How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study

SIMPLE SUMMARY: We aimed to determine ‘what quality criteria do survivorship experts consider to be important in achieving optimal cancer survivorship care?’. An online modified reactive Delphi study was conducted over two rounds. Experts included consumers, clinicians, researchers, policymakers and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lisy, Karolina, Ly, Lena, Kelly, Helana, Clode, Melanie, Jefford, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150859/
https://www.ncbi.nlm.nih.gov/pubmed/34064957
http://dx.doi.org/10.3390/cancers13102299
_version_ 1783698248110702592
author Lisy, Karolina
Ly, Lena
Kelly, Helana
Clode, Melanie
Jefford, Michael
author_facet Lisy, Karolina
Ly, Lena
Kelly, Helana
Clode, Melanie
Jefford, Michael
author_sort Lisy, Karolina
collection PubMed
description SIMPLE SUMMARY: We aimed to determine ‘what quality criteria do survivorship experts consider to be important in achieving optimal cancer survivorship care?’. An online modified reactive Delphi study was conducted over two rounds. Experts included consumers, clinicians, researchers, policymakers and quality and accreditation groups. In round 1, experts ranked the importance of 68 criteria, derived from the international literature across three domains: Policy, process and outcome. In round 2, experts ranked their top 10 criteria per domain. These 30 items formed the Quality Framework. A consensus meeting considered priority items from the Quality Framework and the feasibility of data collection. Prioritized items focused on having a policy supporting provision of survivorship care; the existence of a survivorship program (policy); appropriate processes to assess survivors’ needs following treatment and to stratify to appropriate models of care (process); and reporting survivors’ patient-reported outcomes, quality of life and survival rates (outcome). ABSTRACT: This research sought to answer the question ‘what quality criteria do survivorship experts consider to be important in achieving optimal cancer survivorship care?’. An online modified reactive Delphi survey consisting of two rounds was completed with experts including consumers, clinicians, researchers, policymakers and quality and accreditation professionals. Survey items were based on international literature and considered three domains: Policy, process and outcome. In round 1 (R1), experts ranked the importance of 68 criteria on a five-point Likert scale. Criteria were retained if scored 4 (important) or 5 (very important) by >75% participants. In round 2 (R2), experts ranked top 10 criteria per domain. Response rates were 79% (70/89) and 84% (76/91), respectively. After R1, six criteria were removed and six were added. From R2, ten items for each domain were retained. These 30 items formed the Quality Framework. A consensus meeting considered priority items from the Quality Framework and feasibility of data collection. Prioritized items included having a policy on survivorship care; the existence of a multidisciplinary survivorship program (policy); appropriate processes to assess survivors’ emotional, psychological and physical needs following treatment and stratification to appropriate models of care (process); and collecting patient-reported outcomes, quality of life and survival rates (outcome).
format Online
Article
Text
id pubmed-8150859
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81508592021-05-27 How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study Lisy, Karolina Ly, Lena Kelly, Helana Clode, Melanie Jefford, Michael Cancers (Basel) Article SIMPLE SUMMARY: We aimed to determine ‘what quality criteria do survivorship experts consider to be important in achieving optimal cancer survivorship care?’. An online modified reactive Delphi study was conducted over two rounds. Experts included consumers, clinicians, researchers, policymakers and quality and accreditation groups. In round 1, experts ranked the importance of 68 criteria, derived from the international literature across three domains: Policy, process and outcome. In round 2, experts ranked their top 10 criteria per domain. These 30 items formed the Quality Framework. A consensus meeting considered priority items from the Quality Framework and the feasibility of data collection. Prioritized items focused on having a policy supporting provision of survivorship care; the existence of a survivorship program (policy); appropriate processes to assess survivors’ needs following treatment and to stratify to appropriate models of care (process); and reporting survivors’ patient-reported outcomes, quality of life and survival rates (outcome). ABSTRACT: This research sought to answer the question ‘what quality criteria do survivorship experts consider to be important in achieving optimal cancer survivorship care?’. An online modified reactive Delphi survey consisting of two rounds was completed with experts including consumers, clinicians, researchers, policymakers and quality and accreditation professionals. Survey items were based on international literature and considered three domains: Policy, process and outcome. In round 1 (R1), experts ranked the importance of 68 criteria on a five-point Likert scale. Criteria were retained if scored 4 (important) or 5 (very important) by >75% participants. In round 2 (R2), experts ranked top 10 criteria per domain. Response rates were 79% (70/89) and 84% (76/91), respectively. After R1, six criteria were removed and six were added. From R2, ten items for each domain were retained. These 30 items formed the Quality Framework. A consensus meeting considered priority items from the Quality Framework and feasibility of data collection. Prioritized items included having a policy on survivorship care; the existence of a multidisciplinary survivorship program (policy); appropriate processes to assess survivors’ emotional, psychological and physical needs following treatment and stratification to appropriate models of care (process); and collecting patient-reported outcomes, quality of life and survival rates (outcome). MDPI 2021-05-11 /pmc/articles/PMC8150859/ /pubmed/34064957 http://dx.doi.org/10.3390/cancers13102299 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lisy, Karolina
Ly, Lena
Kelly, Helana
Clode, Melanie
Jefford, Michael
How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
title How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
title_full How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
title_fullStr How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
title_full_unstemmed How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
title_short How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
title_sort how do we define and measure optimal care for cancer survivors? an online modified reactive delphi study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150859/
https://www.ncbi.nlm.nih.gov/pubmed/34064957
http://dx.doi.org/10.3390/cancers13102299
work_keys_str_mv AT lisykarolina howdowedefineandmeasureoptimalcareforcancersurvivorsanonlinemodifiedreactivedelphistudy
AT lylena howdowedefineandmeasureoptimalcareforcancersurvivorsanonlinemodifiedreactivedelphistudy
AT kellyhelana howdowedefineandmeasureoptimalcareforcancersurvivorsanonlinemodifiedreactivedelphistudy
AT clodemelanie howdowedefineandmeasureoptimalcareforcancersurvivorsanonlinemodifiedreactivedelphistudy
AT jeffordmichael howdowedefineandmeasureoptimalcareforcancersurvivorsanonlinemodifiedreactivedelphistudy